
info@juzhikan.asia
School of Southwest Petroleum University, Sichuan China,610500;
Abstract: China’s healthcare system is characterized by concentrated high-quality resources and underused primary care institutions. Using panel data for 31 provinces from 2010 to 2023, this study applies a difference-in-differences model to estimate the effect of the hierarchical medical system reform on primary care utilization. The baseline results show that the reform increased the share of visits to primary care institutions in pilot provinces by about 1.6 percentage points, although the statistical significance is modest. Event-study estimates indicate that the effect emerged gradually within one to two years after implementation. Regional heterogeneity analysis shows a stronger response in central China, while no stable significant effect is found in eastern or western China. Mechanism tests suggest that the reform does not mainly work through a simple expansion of primary care resources; instead, insurance payment incentives and institutional coordination appear to play a more important role. Robustness checks largely support the direction of the main findings, although statistical significance weakens under some alternative specifications. The results imply that the hierarchical medical system reform should continue to be advanced in coordination with health insurance payment reform, referral arrangements, and primary care capacity building, with policy implementation tailored to regional differences.
Keywords: hierarchical medical system reform; primary care utilization; difference-in-differences; regional heterogeneity; mechanism analysis
References
[1] General Office of the State Council of the People’s Republic of China. Guiding Opinions on Promoting the Development of the Tiered Diagnosis and Treatment System. 2015.
[2] General Office of the State Council of the People’s Republic of China. Guiding Opinions on Promoting the Development of Medical Consortia. 2017.
[3] National Health Commission of the People’s Republic of China, National Administration of Traditional Chinese Medicine. Guiding Opinions on Regulating the Management of Family Doctor Contract Services. 2018.
[4]National Healthcare Security Administration. Policy Interpretation of the Notice on Issuing the Version 2.0 Grouping Scheme for DRG and DIP Payment and Further Promoting Related Work. 2024.
[5]Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83(3):457–502.
[6]Forrest CB. Primary care gatekeeping and referrals: effective filter or failed experiment? BMJ. 2003;326(7391):692–695.
[7]Wang S, Cheng F, Xu J. The impact of family doctor contract services on the utilization of and satisfaction with primary health care among Chinese residents: a cross-sectional study. J Family Med Prim Care. 2024;13(5):1887–1893.
[8]Fu P, Wang Y, Zhao D, Yang S, Zhou C. Does contracting family doctor promote primary healthcare utilization among older adults? Evidence from a difference-in-differences analysis. BMC Geriatr. 2024;24:749.
[9]Innocenti F, McCormick B, Nicodemo C. Gatekeeping in primary care: Analysing GP referral patterns and specialist consultations in the NHS. Econ Model. 2025;142:106925.
[10]Miao YD, Wu J, Niu YD, Zhang L. A retrospective review of the hierarchical diagnosis and treatment system and key policy recommendations during the 14th Five-Year Plan period. Chinese Journal of Health Policy. 2021;14(3):1–6.
[11]General Office of the CPC Central Committee; General Office of the State Council of the People’s Republic of China. Opinions on further improving the healthcare service system. 2023.
[12]Yang X, Chen Y, Li C, Hao M. Effects of medical consortium policy on health services: an interrupted time-series analysis in Sanming, China. Front Public Health. 2024;12:1322949.
[13]Bi YN, Liu YA. GPs in UK: From health gatekeepers in primary care to health agents in primary health care. Risk Manag Healthc Policy. 2023;16:1929–1939.
[14]Feng J, Lü SN, Wang Z. Medical resource sharing and patients’ healthcare choices: A policy evaluation of medical consortium reform in China. Management World. 2022;38(10):144–157, 173.
[15]CPC Central Committee, State Council. Healthy China 2030 Planning Outline. 2016.